Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
10 2023
Historique:
medline: 5 10 2023
pubmed: 3 10 2023
entrez: 3 10 2023
Statut: epublish

Résumé

In this Policy Forum piece, Aditya Narayan and colleagues discuss the challenges and opportunities for tuberculosis preventive treatment in carceral settings.

Identifiants

pubmed: 37788448
doi: 10.1371/journal.pmed.1004288
pii: PMEDICINE-D-23-01276
pmc: PMC10547494
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1004288

Informations de copyright

Copyright: © 2023 Narayan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The spouse of SS was employed by Merck Pharmaceuticals 1997-2007 and retains stock in his retirement account. There is no conflict of interest with the submitted work, but is included in the interest of full disclosure. The other authors have declared that no competing interests exist.

Références

BMC Med. 2018 Aug 3;16(1):122
pubmed: 30071850
Nat Med. 2021 Jul;27(7):1171-1177
pubmed: 34031604
Lancet. 2021 Apr 24;397(10284):1591-1596
pubmed: 33838724
BMC Med. 2016 Mar 23;14:45
pubmed: 27004413
Lancet Public Health. 2023 Jul;8(7):e511-e519
pubmed: 37393090
Lancet Reg Health Am. 2022 Nov 04;17:100388
pubmed: 36776567
Ann Intern Med. 2021 Oct;174(10):1367-1376
pubmed: 34424730
Public Health Rep. 2019 May/Jun;134(1_suppl):71S-79S
pubmed: 31059418
Lancet. 2014 Aug 23;384(9944):682-90
pubmed: 24835842
Am Rev Respir Dis. 1967 Jun;95(6):935-43
pubmed: 6026165
Int J Tuberc Lung Dis. 2012 Jul;16(7):871-9
pubmed: 22410101
Int J Tuberc Lung Dis. 2022 Oct 1;26(10):956-962
pubmed: 36163657
Lancet Public Health. 2023 Apr;8(4):e305-e310
pubmed: 36780916
BMC Infect Dis. 2015 Jan 22;15:24
pubmed: 25608746
N Engl J Med. 2011 Jul 7;365(1):11-20
pubmed: 21732833
Ann Am Thorac Soc. 2022 Aug;19(8):1313-1319
pubmed: 34914539
Eur Respir J. 2022 May 19;59(5):
pubmed: 35589114
Int J Tuberc Lung Dis. 2014 Aug;18(8):912-8
pubmed: 25199004
Int J Drug Policy. 2013 Nov;24(6):e91-8
pubmed: 24360402
Lancet. 2016 Sep 10;388(10049):1089-1102
pubmed: 27427453
Lancet Reg Health Am. 2022 May;9:
pubmed: 35647574
Clin Infect Dis. 2020 Apr 15;70(9):1958-1965
pubmed: 31190072
Open Forum Infect Dis. 2016 Jan 06;3(1):ofv220
pubmed: 26885547
Clin Infect Dis. 2012 Mar;54(6):784-91
pubmed: 22267721
Lancet Glob Health. 2017 Nov;5(11):e1080-e1089
pubmed: 29025631
Int J Tuberc Lung Dis. 2022 Aug 1;26(8):741-746
pubmed: 35898140
Lancet Public Health. 2021 May;6(5):e300-e308
pubmed: 33765455
Lancet. 2011 May 7;377(9777):1588-98
pubmed: 21492926
N Engl J Med. 2019 Mar 14;380(11):1001-1011
pubmed: 30865794
Arch Intern Med. 2002 May 13;162(9):1044-50
pubmed: 11996616
Am J Public Health. 1998 Feb;88(2):223-6
pubmed: 9491011
Clin Infect Dis. 2016 Oct 15;63(8):1094-1104
pubmed: 27343545

Auteurs

Aditya Narayan (A)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America.

Argita D Salindri (AD)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America.

Salmaan Keshavjee (S)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.

Monde Muyoyeta (M)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Kavindhran Velen (K)

Implementation Division, The Aurum Institute, Johannesburg, South Africa.

Zulma V Rueda (ZV)

Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.
Research Department, School of Medicine, Universidad Pontificia Bolivariana, Medellin, Colombia.

Julio Croda (J)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America.
Oswaldo Cruz Foundation, Campo Grande, Brazil.

Salome Charalambous (S)

Implementation Division, The Aurum Institute, Johannesburg, South Africa.
Wits School of Public Health, Johannesburg, South Africa.

Alberto L García-Basteiro (AL)

ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Manhiça Health Research Center, Maputo, Mozambique.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.

Sheela V Shenoi (SV)

Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America.

Crhistinne C M Gonçalves (CCM)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.

Liliane Ferreira da Silva (L)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.

Lia G Possuelo (LG)

Department of Life Sciences, Santa Cruz do Sul University, Santa Cruz do Sul, Brazil.

Sarita Aguirre (S)

National Tuberculosis Control Program, Ministry of Public Health and Social Welfare (MSPyBS), Asunción, Paraguay.

Gladys Estigarribia (G)

Instituto Regional de Investigación en Salud, Caaguazú, Paraguay.

Guillermo Sequera (G)

Department of Public Health, Facultad de Ciencias Médicas, Universidad Nacional de Asunción, Asunción, Paraguay.

Louis Grandjean (L)

Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, United Kingdom.

Lily Telisinghe (L)

London School of Hygiene and Tropical Medicine, London, United Kingdom.

Michael E Herce (ME)

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Fernanda Dockhorn (F)

Ministry of Health, Health and Environmental Surveillance Secretariat, General Coordination for Tuberculosis, Endemic Mycoses and Non-Tuberculous Mycobacteria Surveillance, Brasília, (DF) Brazil.

Frederick L Altice (FL)

Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America.

Jason R Andrews (JR)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH